I think I think the overall conclusion from this [paper] is that there is some evidence that pharmacotherapy for obesity changes food preferences in some people, he said
Kevin Sheng-Kai Ma, DDS, FRSPH, FRSM, international scholar at the Center for Global Health at the Perelman School of Medicine at the University of Pennsylvania and lead author of this study, told Medical News Today that he and his colleagues were not surprised by these findings, as these [obesity and obesity-related issues] are indications for GLP-1RA that have been approved in recent years. That said, clinicians are encouraged to monitor and continue assessing patients receiving GLP-1RA [drugs], he advised
Research laboratories across the country face critical decisions when sourcing peptides for their s
Both are powerful tools, but working with a peptide expert ensures you're choosing whats best for your body
doi: 10.5411/wji.v10.i1.1